Accelerating the Pace Toward the End of the HIV Epidemic

In this live, in-person symposium, expert faculty from around the globe will discuss on how healthcare professionals can advance efforts toward ending the HIV epidemic by focusing on key priorities including reaching those who are still undiagnosed, maximizing linkage to ongoing care for people who test positive (or negative), optimizing antiretroviral initiation for both patient health and public health benefits, and optimizing HIV treatment persistence. In addition, contributions from patients living with HIV will be included to provide their perspectives on each topic.

Please note: You must be registered to attend The 24th International AIDS conference to attend this symposium. To register:


Reaching the undiagnosed, didactic presentation followed by a panel discussion

Care pathways after HIV testing, didactic presentation followed by a panel discussion

Keys to successful treatment initiation, didactic presentation followed by a panel discussion

Sustained success: persistence on ART, didactic presentation followed by a panel discussion

Attendee questions answered by experts


Date / Time
Event Details


Program Director
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

Chief Operating Officer
Desmond Tutu HIV Foundation
Deputy Director
Desmond Tutu HIV Centre
Immediate Past President
International AIDS Society
Faculty of Health Sciences
University of Cape Town,
Cape Town, South Africa

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD

Chief and Director
VHS Infectious Diseases Medical Centre
Voluntary Health Services
Chennai, India

Chloe Orkin, MBChB, FRCP, MD

Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Goal Statement
The goal of this activity is to improve learners’ competence in deploying strategies to address key gaps in HIV diagnosis and treatment and contribute to progress toward ending the HIV epidemic.

Target Audience
This program is intended for physicians, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply strategies to improve rates of HIV screening, especially in settings with disproportionate rates of under diagnosis, and to minimize loss to follow-up during linkage to treatment or prevention services
  • Integrate practical interventions to ensure prompt initiation of guideline-recommended ART regimens to benefit both individual and public health
  • Implement approaches to ensure long-term persistence on ART, including attention to patient satisfaction with their regimens and the potential impact of socioeconomic barriers


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-151-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.